Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Jasper Therapeutics: Q3 Earnings Insights

Jasper Therapeutics (NASDAQ:JSPR) reported its Q3 earnings results on Thursday, November 9, 2023 at 08:00 AM. Here’s what…
byBenzinga Insights
November 9, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

Jasper Therapeutics (NASDAQ:JSPR) reported its Q3 earnings results on Thursday, November 9, 2023 at 08:00 AM.

Here’s what investors need to know about the announcement.

Earnings

Jasper Therapeutics missed estimated earnings by 6.67%, reporting an EPS of $-0.16 versus an estimate of $-0.15.

Revenue was down $0 from the same period last year.

Past Earnings Performance

Last quarter the company missed on EPS by $0.0 which was followed by a 1.42% drop in the share price the next day.

** Listen to the earnings announcement yourself by clicking here. **

To track all earnings releases for Jasper Therapeutics visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts
Read More

Earnings Outlook For Lesaka Technologies

By Benzinga Insights
September 8, 10:53 AM
Lesaka Technologies (NASDAQ:LSAK) is set to give its latest quarterly earnings report on Friday, 2022-09-09. Here's what investors need to know before the announcement. Analysts estimate that Lesaka Technologies will report an earnings per share (EPS) of $-0.08.

LSAK